United States Eosinophilic Disorders Market to hit US$ 278 Million By 2031 | Leading Companies - Novartis A.G, GlaxoSmithKline Plc., Teva Pharmaceutical, Pfizer Inc.

Market Size and Forecast:

The Global Eosinophilic Disorders Market reached US$ 150 million in 2023 and is expected to reach US$ 278 million by 2031 growing with a CAGR of 7.1% during the forecast period 2024-2031.

The Eosinophilic Disorders Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/eosinophilic-disorders-market?ca

Eosinophilic disorders are a group of conditions characterized by the overproduction and accumulation of eosinophils, a type of white blood cell, leading to inflammation and tissue damage. These disorders can affect various organs such as the lungs, skin, and gastrointestinal tract, and include conditions like eosinophilic esophagitis and hypereosinophilic syndrome. Treatment typically involves corticosteroids, biologics, and targeted therapies to control inflammation and reduce eosinophil levels.

Recent Key Developments of United States and Japan:

USA

September 24, 2025: The FDA granted Fast Track designation to NS-229 (a JAK1 inhibitor) for Eosinophilic Granulomatosis with Polyangiitis (EGPA), accelerating the development of a potential oral, small-molecule option for this severe, multi-organ eosinophilic disorder.

September 2025: Final results from the EXHALE-4 Phase 3 trial for dexpramipexole were presented, showing the investigational oral add-on therapy significantly improved lung function in patients with eosinophilic asthma, validating a non-biologic, anti-eosinophil mechanism.

Japan

August 13, 2025: Multiple Phase 2 studies for Eosinophilic Esophagitis (EoE) treatments were underway, including trials for EP-104GI (Eupraxia) and solrikitug (Uniquity One), indicating a robust pipeline and ongoing clinical investment in local, targeted EoE therapies.

July 3, 2025: Real-world data on fenfluramine use in adult Lennox-Gastaut Syndrome (LGS) was published by Japanese researchers, reinforcing the clinical focus on the use of anti-seizure drugs (AEDs) and specialty pharmaceuticals, which share the same drug development focus as some emerging eosinophilic disorder treatments.

List of the Key Players in the Eosinophilic Disorders Market:

Novartis A.G
GlaxoSmithKline Plc.
Teva Pharmaceutical
Pfizer Inc.
AstraZeneca
Sanofi S.A
Curia
LGM Pharma
Henan Lihua Pharmaceuticals Ltd.
Hikma Pharmaceuticals

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/eosinophilic-disorders-market?ca

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Eosinophilic Disorders Market Market:

➥ By Type: Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Enteritis, Eosinophilic Colitis, Hypereosinophilic Syndrome
➥ By Treatment: Medications, Dietary Therapy, Dilation, Others
➥ By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=eosinophilic-disorders-market?ca

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Eosinophilic Disorders Market Market market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Eosinophilic Disorders Market Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Eosinophilic Disorders Market Market leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Eosinophilic Disorders Market Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ca

People Also Ask:

◆ How big is the Eosinophilic Disorders Market in 2025?
◆ What is the projected growth rate of the Eosinophilic Disorders Market through 2033?
◆ Who are the key players in the Eosinophilic Disorders Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.